## |Trustees|and advisors||| |---|---|---|---| |Board of|Trustees'
report||2-18| |Independent
auditor's||report|19-21| |Statement|offinancial|activities|22| |Summary|income and|expenditure|24| |Balance sheet|||25| |Statement|ofcash flows||26| |Notes to|the financial|statements|27-43| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |POTENTIAL
RISKS|POTENTIAL
RISKS||ACTION TAKEN TO LESSEN
IMPACT/LIKELIHOOD||ACTIONS TO BETAKEN OR
ON-GOING TO LESSEN|ACTIONS TO BETAKEN OR
ON-GOING TO LESSEN|ACTIONS TO BETAKEN OR
ON-GOING TO LESSEN|ACTIONS TO BETAKEN OR
ON-GOING TO LESSEN| |---|---|---|---|---|---|---|---|---| ||||||IMPACT/LIKELIHOOD|||| |COVID-19 epidemic|||Strict budgetary
controls on|~|Monthly
SMT review|of income||| |and economic|||expenditure,||and expenditure.|||| |downturn
significantly
impact
financial
security of
organisation.|||Cautious
income targets set for 2020-
21 budget.
Made use of Govt furlough
scheme.|~|Apply for emergency
where e!igible.|funding||| ||||Applied for emergency
funding
where|||||| ||||eligible.|||||| ||||Pay freeze for all staff and reduced|||||| ||||salaries for some senior staff (now|||||| ||||ended).|||||| |||~|Diversify focus on fundraising
team to|||||| ||||include major donors.|||||| |Loss ofsector|||Diversification
offundraising
team||Bring proposals
for|cost cutting||| |specific funders|and||focus to include major donor and||measures
including|moving||| |changes
in funding|||corporate,||offices to Board.|||| |patterns
threaten
organisational
sustainability.|||Development
of robust Fundraising
Strategy.
Development
of Board Fundraising||Continued
close scrutiny
of
progress.
Use strategic
plan to drive new|||| ||||Committee.||opportunities.|||| ||||Regular Board led group to explore|||||| ||||options to resolve this issue.|||||| ||||Robust scrutiny of progress
by SMT|||||| ||||and Board.|||||| |Staff wellbeing||~|Staff workstation
reviews
undertaken.||Ensure staff have correct|||| |negatively
impacted
by working
from
home and lock
down,|||Use ofonline video meeting
and
instant message technology.
More regular
all staff check-In
meetings.||computer
equipment
and
chairs.
Implement
recommendations
mental
health
group,|||of| ||||Small staff we[lbeing
fund established.|||||| ||||Staff survey on how staff are doing,|||||| ||||Mental
health group working
on|||||| ||||improving
policies and support for|||||| ||||staff.|||||| |Impact of large||~|Careful
planning
for how legacy
will be|~|Clear explanation
of|legacy||| |legacy on financial|||invested,
to prioritise
organisational||spending
in relevant|statutory||| |position discourages|||sustainability,
core activities and||accounts.|||| |trust and individual
funders
from
donating.|||reserves.
Creation ofdesignated
reserves to
indicate
non-availability
of legacy for|~|Careful
planning
for
monitoring
oflegacy|spend and
spend.||| ||||day-to-day
operations.|||||| ## ## ## ## |at|30June 2021 our Board of|Trustees comp|rised:||| |---|---|---|---|---|---| |~|Professor Jane Anderson|CBE|~|Stephen
Crampton-Hayward
*|| ||(Chair) **/"**||~|Andrew
Hochhauser|QC */***| |~|Kathleen
Britain */"**||||| ||||~|I-Iarry McAnulty|| |~
~|Gary Christie
Dr Valerie Delpech **||~
~|Angelina
Namiba **
Peter Roscrow *|| |~|James Dray ***||~|Dr Olwen Williams|| |~|Ceri Edwards ***||~|Dr Lee Winter */***|| |a|Judy Hague */"*||||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Current financial year|Current financial year|||||||| |---|---|---|---|---|---|---|---|---| ||||Unrestricted|Unrestricted|Restricted|Endowment|Total|Total| ||||funds|funds|funds|funds||| ||||general|designated||||| ||||2020-21|2020-21|2020-21|2020-21|2020-21|2019-20| |||Notes|K|||E|F|R| |Income from:||||||||| |Donations
and legacies|||294,567||279,272|259,242|833,081|689,071| |Charitable
activities|||160,612||||160,612|85,308| |Investments|||4,072||||4,072|7,013| |Total income and||||||||| |endowments|||459,251||279,272|259,242|997,765|781,392| |Raising funds||6|136,221||||136,221|163,385| |Charitable
activitIes||7|383,123|87,095|282,419||752,637|770,260| |Total resources||||||||| |expended|||519,344|87,095|282,419||888,858|933,645| |Net||||||||| |(outgoing)/incoming||||||||| |resources before|||(60,093)|(87,095)|(3,147)|259,242|108,907|(152,253)| |Gross transfers|between|||||||| |funds|||307,947|(304,387)|(3,560)|||| |Net movement|in funds||247,854|(391,482)|(6,707)|259,242|108,907|(152,253)| |Fund balances at I July||||||||| |2020|||475,711|391,482|81,727||948,920|1,101,173| |Fund balances|at 30|||||||| |June 2021|||723,565||75,020|259,242|'l,057,827|948,920| ## ## |Prior financial year|||||||| |---|---|---|---|---|---|---|---| ||||Unrestricted|Unrestricted||Restricted|Total| ||||funds||funds|funds|| ||||general||designated||| ||||2019-20||2019-20|2019-20|2019-20| |||Notes|||||E| |Income from:|||||||| |Donations
and legacies|||493,969|||195,102|689,071| |Charitable
activities|||85,308||||85,308| |Investments|||7,013||||7,013| |Total income and endowments|||586,290|||195,102|781,392| |~Ex enditure
on:|||||||| |Raising funds|||163,385||||163,385| |Charitable
activities|||473,846||108,109|188,305|770,260| |Total resources expended|||637,231||108,109|188,305|933,645| |Net (outgoing)/incoming|resources before||||||| |transfers|||(50,941)||(108,109)|6,797|(152,253)| |Gross transfers
between|funds||48,940||(48,940)||| |Net movement
in funds|||(2,001)||(157,049)|6,797|(152,253)| |Fund balances at 1 July|2019||477,712||548,531|74,930|1,101,173| |Fund balances at 30June 2020|||475,711||391,482|81,727|948,920| ## ## ## |||AII income funds|| |---|---|---|---| |||2020-21|2019-20| ||||E| |Gross income||T38,523|781,392| |Total expenditure|from income funds|888,858|933,645| |Net expenditure|for the year|(150,335)|(152,253)| ## ## ## |||||2020-21|2019-20| |---|---|---|---|---|---| ||||Notes||| |Fixed assets|||||| |Tangible assets|||11|16,699|20,551| |Endowment
investment|||12|259,242|| |||||275,941|20,551| |Current assets|||||| |Stocks|||13|22,393|19,664| |Debtors falling due|after one year||14|13,511|13,511| |Debtors falling due|within one year||14|63,087|125,320| |Cash at bank and|in|hand||797,703|917,278| |||||896,694|1,075,773| |Creditors: amounts||falling due within|||| |one year|||15|(114,808)|(147,404)| |Net current assets||||781,886|928,369| |Total assets less|current liabilities|||1,057,827|948,920| |Capital funds|||||| |Expendable
endowment|||17|259,242|| |Income funds|||||| |Restricted funds||||75,020|81,727| |Unrestricted
funds|-|eneral|||| |Designated
funds|||||391,482| |General unrestricted||funds||723,565|475,711| |||||723,565|867,193| |||||1,057,827|948,920| ## ## ## ||||||||2020-21|20'l9-20| |---|---|---|---|---|---|---|---|---| |||||||Notes||| |Cash flows from operating||||activities||||| |Cash generated
from/(absorbed|||||by)|25||| |operations|||||||141,701|(48,453)| |investing|activities|||||||| |Purchase|oftangible|fixed|assets||||(6,106)|(5,841)| |interest received|||||||4,072|7,013| |Net cash|(used in)/generated|||from||||| |investing|activities||||||(2,034)|1,172| |Net increase/(decrease)|||in|cash and||cash||| |equivalents|||||||139,667|(47,281)| |Cash and|cash equivalents||at beginning|||ofyear|917,278|964,559| |Cash and|cash equivalents|||at end of||year|1,056,945|917,278| |Relating|to:|||||||| |Cash at bank and in||hand|||||797,703|917,278| |deposits|included
in|fixed|asset investments|||||| ||||||||259,242|| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||Total|Total| |---|---|---|---|---| ||||2020-21|2019-20| |Grants|(F5,000+) plus all pharmaceutical|funding|386,559|476,655| |Other|grants and donations||446,522|212,416| ||||833,08'I|689,071| ## ## ## ## |Grants (f5,000+)plus
Gilead Sciences Ltd|all|pharmaceutical|funding|99,745|30,238| |---|---|---|---|---|---| |The Baring Foundation||||68,000|34,000| |M.A.C AIDS Fund (Viva|Glarn)|||50,000|166,193| |ViiV Healthcare
UK Limited||||45,792|62,302| |Big Lottery Fund||||38,144|| |Mill Charitable
Trust||||30,000|30,000| |Trust for London||||24,000|36,500| |Coronavirus
Job Retention||Grant||12,877|33,660| |City Bridge Trust||||10,400|| |Janssen-Cilag
Ltd||||5,000|4,000| |Merck, Sharpe 8 Dohme||Ltd||2,600|| |Elton John AIDS Foundation|||||45,000| |Public Health
England|||||12,962| |Martin
Bowley Charitable||Trust|||7,000| |Positively
UK|||||4,800| |Pfizer Limited|||||10,000| |||||386,559|476,655| |Individual
8 community||||117,367|115,807| |Corporate
donations||||40,498|45,934| |Trusts 8 foundations||||2,500|2,550| |European
international|funding|||1,715|4,995| |Legacies||||284,442|43,130| |||||446,522|212,416| |Charitable|activiti|es||||| |---|---|---|---|---|---|---| ||||||2020-21|2019-20| |||||||F| |European|international||project funding||76,293|56,394| |Healthy
London Partnership|||||68,975|| |Awareness|raising|through||red ribbon products|13,162|27,934| |Other income|||||2,182|980| ||||||160,612|85,308| ## ## ## ||||Total|Total| |---|---|---|---|---| ||||2020-21|2019-20| |||||F| |Interest receivable|||4,072|7,013| |All ofthe charity's|investment|income arises from interest bearing accounts.||| ## ||||Total|Total| |---|---|---|---|---| ||||2020-21|2019-20| |||||E| |Fundraising|salaries||111,480|117,168| |Associated|operating|costs|2,463|11,917| |Support costs|||22,278|34,300| ||||136,221|163,385| ## ## ## ## ||||2020-21|2019-20| |---|---|---|---|---| |Policy work &campaigning||||| |Staff costs|||411,486|473,829| |Other direct charitable||expenditure|120,032|28,789| ||||531,518|502,618| |Share ofsupport costs (see note 8)|||168,133|203,428| |Share ofgovernance||costs (see note 8)|52,986|64,214| ||||752,637|770,260| |Analysis
by fund||||| |Unrestricted
funds|- general||383,123|473,846| |Unrestricted
funds|—designated||87,095|108,109| |Restricted
funds|||282,419|188,305| ||||752,637|770,260| ## ## |8|Support costs|Support costs||||||||| |---|---|---|---|---|---|---|---|---|---|---| ||||||Support|Governance|2020-21|Support costs|Governance|2019-20| ||||||costs|costs|||costs|| ||||||E|||||| ||Staff costs||||78,407|42,750|121,157|104,290|35,201|139,491| ||Depreciation||||9,958||9,958|12,598||12,598| ||Non salary|staffing|8|||||||| ||recruitment|costs|||5,447||5,447|15,910||15,910| ||Office expenditure||||6,081||6,081|6,894||6,894| ||Telephone|8 internet|||4,020||4,020|4,080||4,080| ||Website &|IT|||31,591||31,591|23,340||23,340| ||Premises
expenditure||||51,295||51,295|68,172||68,172| ||Insurance||||2,429||2,429|2,444||2,444| ||Support costs heading|||8|1,183||1,183|||| ||Audit fees|||||5,280|5,280||5,280|5,280| ||Legal and|professional||||1,013|1,013|||| ||Other fees|paid to the||||||||| ||auditors|||||1,680|1,680||1,680|1,680| ||Strategic planning||||||||21,404|2'f,404| ||Trustees' expenses|||||2,263|2,263||649|649| ||||||190,411|52,986|243,397|237,728|64,214|301,942| ||Analysed
between|||||||||| ||Fundraising||||22,278||22,278|34,300||34,300| ||Charitable|activities|||168,133|52,986|221,119|203,428|64,214|267,642| ||||||190,411|52,986|243,397|237,728|64,214|301,942| ## ## ## ## ## |Number ofe|mployees||||| |---|---|---|---|---|---| |The average|staff headcount|during|the year was as follows:||| |||||2020-21|2019-20| |||||Number|Number| |||||17|19| |Employment|costs|||2020-21|2019-20| ||||||K| |Wages and salaries||||558,692|635,464| |Social security costs||||53,611|59,036| |Other pension costs||||31,820|35,988| |||||644,123|730,488| |||||Total|Total| |Employment|costs by department|||2020-21|2019-20| |||||f.|| |Core policy work||||411,486|473,829| |Fundraising||||111,480|117,168| |Support 8 governance||||121,157|139,491| |||||644,123|730,488| |The number
of employees
whose
annual
remunerat
were:|ion
was f60,000 or more|| |---|---|---| ||2020-21|2019-20| ||Number|Number| |260,000-270,000|1|1| ## ## ## |11|Tangible fixed assets|||| |---|---|---|---|---| ||||Equipment,|fixtures and fittings| ||Cost|||| ||At 1 July 2020|||93,745| ||Additions|||6,106| ||Disposals|||(9,208)| ||At 30June 2021|||90,643| ||Depreciation
and impairment|||| ||At 1 July 2020|||73,194| ||Depreciation
charged|in the year||9,958| ||Eliminated
in respect ofdisposals|||(9,208)| ||At 30June 2021|||73,944| ||Carrying
amount|||| ||At 30June 2021|||16,699| ||At 30June 2020|||20,551| |12|Fixed asset investments|||| |||||Cash| ||Cost or valuation|||| ||At 1 July 2020|||| ||Endowment
funds received|||259,242| ||At 30June 2021|||259,242| ||Carrying
amount|||| ||At 30June 2021|||259,242| ||At 30June 2020|||| ## ## ## |13|Stocks|||||||||| |---|---|---|---|---|---|---|---|---|---|---| ||||||||||2020-21|2019-20| |||||||||||f.| ||Stacks|of|Red|Ribbon|lapel|pins|and|broaches|22,393|19,664| |14|Debtors||||| |---|---|---|---|---|---| |||||2020-21|2019-20| ||Amounts
falling due|within one year:|||F| ||Grants and donations|receivable||2,014|114,238| ||Prepayments
and accrued income|||61,073|11,082| |||||63,087|125,320| |||||2020-21|2019-20| ||Amounts
falling due after more than one year:||||| ||Rent deposit|||13,511|13,511| ||Total debtors|||76,598|138,831| |15|Creditors. "amounts|falling due within one year|||| |||||2020-21|2019-20| ||||Notes||| ||Other taxation and social secudty|||15,006|17,377| ||Deferred
income||16||62,689| ||Trade creditors|||59,083|1,599| ||Other creditors|||602|| ||Accruals and other creditors|||40,117|65,739| |||||114,808|147,404| ## ## ## ## ## |||||Movement|in funds||| |---|---|---|---|---|---|---|---| |||Balance at|Incoming|Resources|Transfers|Revaluations|Balance at| |||1July 2020|resources|expended||gains and|30June 2021| |||||||losses|| |Expendable|endowments||||||| |Gary Philipp|Endowment||259,242||||259,242| ||||259,242||||259,242| |||||IQ (II
QIa
o Ol
t
S 7|IQ (II
QIa
o Ol
t
S 7|4J|I
I
N
C9|I
I
N
C9|I
I
N
C9|I||CD
Cl|CD
Cl||Cl
N|Cl
N|(D|(D|I|I|I|||O
CIl|O
CIl||CI
(D
UD||||O
Cl
CI
IAN|Cl
N
Cl| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||C7|||||||||||||||||||||||||||| ||||I/O|||||||||||||||||||||||||||||| ||||Ql
IIl0
CL
(=L
O|t
L||||I||I|I|I|I|I||||||I|I|I|I|I||||||||O
(D
IA
CO| |||||I||||||||||||||||||||||||||||| ||||O|||||||||||||||||||||||||||||| ||||Ql|||||||||||||||||||||||||||||| ||||CL|||||||||||||||||||||||||||||| ||||Ill|g
o|D
'I||T
Dl|I||CI3|||||||QO||I|Q
O
C6|I|||UD
UD|O
OO|O|w|CClO||CD||Cl
N| ||||Cfl|O
g|(L
(C
(6|||||IA|||||(D
N|N||||||||N
Yl|Q
CIi|||||IA||CON| ||||0'a|||||||||||||||||||||||||||||| ||||Ql
Ill
Ql|CD
E
o|IU
QIV
o
Ul||Q
O|I|||||||UCI
O|N|||I|CI||||O
O
O
CI7|O
O
O
O|O
O
Q
(A|Q
Q
O
N|||CI&
IA|O
OO
(AN|N
Cb| ||||Pl|||||||||||||||||||||||||||||N| ||||CU|||||||||||||||||||||||||||||| ||||IIl
0
(6C0|IU CI(
Ql O
V Pltg||||||||||I|||CD
CD
N|||I|I|I|I|Dl
N
P7|I||N
Dl
N
P&|O
(D
CO||||| ||||0|||||||||||||||||||||||||||||| ||||(0
OC
CQ
(g|IUa
Ql
QI
V Ot
Cl a||||O
OO
~||Dl
O
N|||IA Q
CIl
(D
~ N||||||0
(A
IA
N|'|Q
CI
Cl
O|O
O
CD|Q||||IA
00
N
YJ|Dl
CIl||||| |||||Ui|UI|||||||||||||||||||||||||||| ||||Ql0C
Ql
l(
Ql|66
E
Cl
o|lO
QI
o
o
e|||O
Q
O|

|O
Q
O
LA|Cl
Cl
Cl
Q
N|CI
N|IA||||Q
Cl||Q
IA
(D
N|'|O
O
O
Q|O
O
UD|IN|O
YJ|I||OO
(A
CD|N||CD
CD
Y)||| ||||al|||||||||||||||||||||||||||||| |0
UlDXI-
R'00|||00
Ql
al
Ill
I
E0
O
(6
'a|~ VI
IIl~
CI O
V N
t~
IU~|||I|I||Q
IA|||I|Q
IA
(A|||||I|I|I||CD
Pl
(D|DlN|I||«D
CD|I||||| ||||C||||||||(D|||||||||||||||||||||| |thI-
K
UJI-
I-
CO
OR
X
LUXI-0I-
l6
I-0z|Lu
0
Ci
04.|(A
'D
C
'D
Ql
O
I
Di
Ql|0
Ql
O
(D
ID
O
Cg
O
Ql
0
IIl
QlE0
O
Ql|||o ~
I
Ill
'0
Ill
C
C
Q
CO
CO
E 0 8
O ~ —„
(D
I
P
(D
Ql
a
L
(6 'C
ID
CD
(D
CU.
0
ZOO
C0
CU
IIl
(6
E
O
I
C
0
(6
'T3C
0
LL
(0
CI
C
S
0
r
0
LLl|||||Ill
Ill
QlO
rh0
e
C
0
Z
I
L
0
I
L
0
LL
CA
Q
C
S
0I
C
0
LLI|al
5l
I
(6
Ql
0|Dl
I
Q
0
O
I
(6
Ql
U|Ql
CUO
al
C
0
E
I
D
(6
Ql|Gl
(D
~
I
(D|QlC
CI(
Ql
0
+
CQ
I
(6|CI
Cl
C(6
QI
O
(6
(6
03
CO
C
0
ch
(6
'a|al
(6
O
Ql
IIl
IIIL
(6|QlE
0
Ci
(D
CL
CU
(0
0
O
Ql
al
cD
N
ZX 0|||N0
D|C
E
E
O
I
C
(g
al
LIJ
CU
Ql
o
CL|(6
al
~
I
C
0
Ql
C
0
U
al
C
CU
Kl
CD|Ql
IDL0
Ill
Ql
Dl
O
)
~
O
I
L
0
Ql
C
0
U
al
C
(6
Q3
Ql
t9
(g
al
O
0
L- (0
CD
CU)
E QlZ
E al
c5
O
L)
0=z(D
DC
C
2 0
CD
0
U
'0
(go
al ~0
(6
(6 0
Ql
CO ~ Z
(6)
2
I- I- 0||||Di
g
0
O ~
I
(D
I
(60 P.
CL
(6
(6
D
06|||| |||||||||||||||||Qj||| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||||||||||||||I||| |||||||||||||||||Ct||| |||||||||||||||||0
O0
0
CD||'0
Ql0| |||||||||||||||||C||| |||||||||||||||||Qj
Ql||| |||||||F||||||||||C)r
eC
e||0
0| |||||||Ol||||||||||||| |||||||||||||||||||ttl| |||||||Ql
Ol||||||||||Oj
Ql||| |||||||CU||||||||||||| |||||||QlN0
!I—
0||||||||||tg
O.0
gj
e||Oj
Ql| |D
z
z0
O
CflI-z|||Ctj
IO)0
O0
Ql
0
gl
YL0
glO.
0
cn'0
gl
N
e
Qj
N
0
Ql
C'o! e
0
QlN ~ X
moe
o
CLt
C I- 0
0
gl
Ql
cn
0
4
Oj
O
.r
CL C 'O
CLm
C
C/j 0 LL
CD|CD
ch
cn
Ql
QlO
cn
CU
CU
'0 C
cg 2
N
O
Ql
cr
0
m
cn
Ql
cn
E'
O
!
CU
e)
0r
a.
Cn
I/l
IO
C '0
CU
CU
In
O
Ne
Ql
'0 0P
O ~
I- &||m
CD
CU
0
tg
CT
Ql
CnL
0
O. CD
E
C g
0)
cn0
C O
c/I 0
0~0
0
C6
,e E
O
m
ch
N
I
CU
N C
m
C
Oj|r
Ol
C
Ql
0
tD
CL
ry
O
N
Q e0
0
CD
N
CU0
CU
O
CD
C0—
CU
Ctl
I
C
OC
Ql
CD
cn
C
0
0
CD
CLE
Ol 'C
c 0
0
t-L
N0
Q I-
CnI: Ol
Lo r
Ql
ch 'gl
~ Cl) e
r I
C Cj
CU
Cj C
Ch
ID
00 .)
I P
p 0
m
CU0
m
0
N
I
ccl 0
4—
E
CD
CUe 'ol
L
CU
W
LL||||L
r mr0
Q
cn
o m~
m 0
m c
O
0 E
Ql
0'r
m
0 0
O
O
C
Cg
m
I/l
er p
Ce'g e
8RO
e c e
C)C
Ol
Ol
0 mW
O C
gl
Q
Lt Z|0
CD0
CU
0
CD
tg
Ol
Ql
.c
c
CU
cn
0
tg
O
C
Ql
Oj
O
LL|Q
~0
cn
C0
to
CL
Ql
O!
e
a.
Ql
Oj
0
~
0
C
'O|ID
0
0
m0
CL
CL
CU
0
Ql!00
tD
In
Ch
Ql
00 0
cn)
r—r
Ne 0
Qj
c D
Ql
E 9
E 0
00~
Ql
O ~
tg
C
E0
CL
0
gl
Cn
C
e
ch
CI D||0
O.
NN
ch
QlOO
tg
C
Ol
0
C
CU
cn
Qj P
L
CL
m '~
Ql ~ '
0
0 g
C
)
CD
cg
r EP
C
Q
0 N'3
ENN
0 O»
O
m ol
C
m0E
2;:
eo
Cjm 0
c m~
CU
glr
CD)
cn
CU
CD
CU
0~
Ql
0
gj
c)
Cn
Cl.
E
cn
cn
tg
owe
I—LL|0
Ql
CL
gl
I
Ql
CL
)
CD
C0
ccp
mI:
Cg
Ol
0
N
cn
Ql
Cg —CU
'0
tg
Cj o
Ql
0
0 ~ L
cD
Ol 66
m
CLC E
CU 0 0
0 Cjj~
50 o
O I—|| |UJX
LII-
I-
CfI
Uz
z
LUzI-0I-
Cfl
l-0z|D
4J
D
0
LuQ
Lu
Lu
04.|th
C
0
0
I
cn
CDIj'|I
I
O.
I
ch
ch
C )
O
'Coen
O&
N
FCO
0
Opo
N
Ql
Ql
I
0—
I OIO
m~ eL
C
cg.
0
ZOO|0
CU
0C
0
LL
C/j
CI
C
0
C
Q
LLI|C
0
CU
C
0
LL
C/I
CI
C
0
r
0
LLI|Ol
C Q
~0
Oj)
O
'0 '0
CU
CU
Ql
Ql
C9 (9|cD
0
Qj
L
0
E
I
Cf
Ql
Ql
(3|CU
Ql
J:
CU
~
I
0
m
e
0|Ol
cn8
0
C6
0
CU|N
O
c
tg
cn
0
'0|QjE
0
C3
CD
CU
m
O
C/j
Qj 0
Na~
cmQj
Qj|Qj
CL|Ql
I/lO
CL|Oj
ch
Ql
E
E
O
CU
Oj
C
e
O
Q|m
Ch
IC0
'0
L
0
Oj
L
'C
CU
Ql
I-|CD
cn
'C0
N
Oj
e!
Ql
I
C
0
O
C3
CU
) E cn
0 0~
r
tg
C
0 0Cj
LL LL 0
Ol Oj~
m 0
CQ
CQ
CD
Ql
I- I- I-|Cjj
I
m
C-I
E)
cn0O
ch) C
r 0 c
Ql
C
0) e
N0 0
I
ID
QI
m
CU
I
I
UJ
0 0 0.
C Z
CL
mme
rrCL
Ql
Ql)) g'|| ## ## ## ||Balance at|Resources|Transfers|Balance at|Resources|Transfers|Balance at| |---|---|---|---|---|---|---|---| ||1 July 2019|expended
f||1 July 2020|expended
K||30June 2021| |Strategic
development|100,000|(21,404)|(?5,000)|3,596|(2,287)|(1,309)|| |Infrastructure|||||||| |and|||||||| |sustainabllity|154,342|(22,183)|(67,147)|65,012|(26,021)|(38,991)|| |Core activities|||||||| ||294,189|(64,522)|(111,793)|117,874|(58,788)|(59,086)|| |Operational|||||||| |costs|||205,000|205,000||(205,000)|| ||548,531|(108,109)|(48,940)|391,482|(87,096)|(304,386)|| ## ## ## |20|Analysis of|net assets between funds|||||| |---|---|---|---|---|---|---|---| ||||Unrestricted|Designated|Restricted|Endowment|Total| ||||funds|funds|funds|funds|| ||||2020-21|2020-21|2020-21|2020-21|2020-21| ||||||f|F|| ||Fund balances at 30June 2021 are||||||| ||represented|by:|||||| ||Tangible assets||16,699||||16,699| ||Investments|||||259,242|259,242| ||Current assets/(liabilities)||706,866||75,020||781,886| ||||723,565||75,020|259,242|1,057,827| ||||Unrestricted|Designated|Restricted|Endowment|Total| ||||funds|funds|funds|funds|| ||||2019-20|2019-20|2019-20|2019-20|2019-20| |||||||R|f| ||Fund balances at 30 June 2020 are||||||| ||represented|by:|||||| ||Tangible assets||20,551||||20,551| ||Current assets/(liabilities)||455,160|391,482|81,727||928,369| ||||475,711|391,482|81,727||948,920| ## ## |||2020-21|2019-20| |---|---|---|---| |||E|| |Within one year||55,400|53,828| |8etween|two and five years|10,025|63,876| |||65,425|117,704| ## ## ## ## ## ||The charity had no debt|during the|year.|||||| |---|---|---|---|---|---|---|---|---| |25|Cash generated
from|operations|||||2020-21
f|2019-20
F| ||Surplus/(deficit)
for the|year|||||108,907|('I52,253)| ||Adjustments
for:
Investment
income recognised
in||statement||offinancial|activities|(4,072)|(7,013)| ||Depreciation
and impairment
oftangible|||fixed assets|||9,958|12,598| ||Movements
in working|capital:||||||| ||(Increase) in stocks
Decrease
in debtors||||||(2,729)
62,233|(19,664)
53,520| ||Increase
in creditors||||||30,093|1,670| ||(Decrease)/increase
in|deferred
income|||||(62,689)|62,689| ||Cash generated
from/(absorbed||by)|operations|||141,701|(48,453)|